MRK
Price
$87.27
Change
-$2.50 (-2.79%)
Updated
Apr 1, 02:50 PM (EDT)
Capitalization
331.75B
23 days until earnings call
PFE
Price
$24.65
Change
-$0.69 (-2.72%)
Updated
Apr 1, 02:53 PM (EDT)
Capitalization
157.14B
28 days until earnings call
Ad is loading...

MRK vs PFE

Header iconMRK vs PFE Comparison
Open Charts MRK vs PFEBanner chart's image
Merck & Co
Price$87.27
Change-$2.50 (-2.79%)
Volume$20.71K
Capitalization331.75B
Pfizer
Price$24.65
Change-$0.69 (-2.72%)
Volume$37.57K
Capitalization157.14B
MRK vs PFE Comparison Chart
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRK vs. PFE commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Hold and PFE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (MRK: $89.76 vs. PFE: $25.34)
Brand notoriety: MRK and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 85% vs. PFE: 110%
Market capitalization -- MRK: $331.75B vs. PFE: $157.14B
MRK [@Pharmaceuticals: Major] is valued at $331.75B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 2 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • MRK’s FA Score: 2 green, 3 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, MRK is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • MRK’s TA Score: 4 bullish, 5 bearish.
  • PFE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PFE is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -2.76% price change this week, while PFE (@Pharmaceuticals: Major) price change was -3.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.53%. For the same industry, the average monthly price growth was -0.90%, and the average quarterly price growth was -6.46%.

Reported Earning Dates

MRK is expected to report earnings on Apr 24, 2025.

PFE is expected to report earnings on Apr 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.53% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than PFE($157B). MRK has higher P/E ratio than PFE: MRK (935.64) vs PFE (74.92). PFE YTD gains are higher at: -2.906 vs. MRK (-8.991). PFE has higher annual earnings (EBITDA): 9.56B vs. MRK (6.91B). PFE has more cash in the bank: 12.7B vs. MRK (7.09B). MRK has less debt than PFE: MRK (35.1B) vs PFE (70.8B). MRK (60.1B) and PFE (58.5B) have equivalent revenues.
MRKPFEMRK / PFE
Capitalization332B157B211%
EBITDA6.91B9.56B72%
Gain YTD-8.991-2.906309%
P/E Ratio935.6474.921,249%
Revenue60.1B58.5B103%
Total Cash7.09B12.7B56%
Total Debt35.1B70.8B50%
FUNDAMENTALS RATINGS
MRK vs PFE: Fundamental Ratings
MRK
PFE
OUTLOOK RATING
1..100
7277
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
2572
PRICE GROWTH RATING
1..100
6259
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
4550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (3) in the Pharmaceuticals Major industry is in the same range as MRK (12). This means that PFE’s stock grew similarly to MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for PFE (100). This means that MRK’s stock grew somewhat faster than PFE’s over the last 12 months.

MRK's SMR Rating (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for PFE (72). This means that MRK’s stock grew somewhat faster than PFE’s over the last 12 months.

PFE's Price Growth Rating (59) in the Pharmaceuticals Major industry is in the same range as MRK (62). This means that PFE’s stock grew similarly to MRK’s over the last 12 months.

PFE's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as MRK (100). This means that PFE’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKPFE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
57%
Declines
ODDS (%)
Bearish Trend 8 days ago
48%
Bearish Trend 6 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
52%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Ad is loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAL25.370.30
+1.20%
Halliburton Company
EIG50.640.27
+0.54%
Employers Holdings
DNB8.940.02
+0.22%
Dun & Bradstreet Holdings
LNKB6.78-0.12
-1.74%
LINKBANCORP
ANY0.40-0.02
-4.87%
Sphere 3D Corp

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+0.59%
AZN - MRK
27%
Poorly correlated
-0.39%
JNJ - MRK
24%
Poorly correlated
+1.30%
NVS - MRK
23%
Poorly correlated
-0.97%
PFE - MRK
23%
Poorly correlated
+0.52%
GSK - MRK
22%
Poorly correlated
N/A
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with JNJ. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.52%
JNJ - PFE
53%
Loosely correlated
+1.30%
GSK - PFE
47%
Loosely correlated
N/A
AMGN - PFE
42%
Loosely correlated
+1.50%
BMY - PFE
39%
Loosely correlated
+1.62%
NVS - PFE
38%
Loosely correlated
-0.97%
More